These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 9933759)

  • 1. Renoprotective effects of captopril in hypertension induced by nitric oxide synthase inhibition in experimental nephritis.
    Uhlenius N; Tikkanen T; Miettinen A; Holthöfer H; Törnroth T; Eriksson A; Fyhrquist F; Tikkanen I
    Nephron; 1999 Feb; 81(2):221-9. PubMed ID: 9933759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renin-angiotensin blockade improves renal cGMP production via non-AT(2)-receptor mediated mechanisms in hypertension-induced by chronic NOS inhibition in rat.
    Uhlenius N; Vuolteenaho O; Tikkanen I
    J Renin Angiotensin Aldosterone Syst; 2001 Dec; 2(4):233-9. PubMed ID: 11881129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic inhibition of nitric oxide synthase in Heymann nephritis.
    Uhlenius N; Tikkanen I; Tikkanen T; Miettinen A; Törnroth T; Fyhrquist F
    Nephron; 1996; 74(1):144-9. PubMed ID: 8883033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of captopril on cardiac and renal damage, and metabolic alterations in the nitric oxide-deficient hypertensive rat.
    Khattab MM; Mostafa A; Al-Shabanah O
    Kidney Blood Press Res; 2005; 28(4):243-50. PubMed ID: 16220007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renoprotective mechanisms of angiotensin II antagonism in experimental chronic renal failure.
    Uhlenius N; Miettinen A; Vuolteenaho O; Tikkanen I
    Kidney Blood Press Res; 2002; 25(2):71-9. PubMed ID: 12077487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal effects of omapatrilat and captopril in salt-loaded, nitric oxide-deficient rats.
    Ying L; Flamant M; Vandermeersch S; Boffa JJ; Chatziantoniou C; Dussaule JC; Chansel D
    Hypertension; 2003 Nov; 42(5):937-44. PubMed ID: 14569001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Captopril prevents NO-deficient hypertension and left ventricular hypertrophy without affecting nitric oxide synthase activity in rats.
    Bernátová I; Pechánová O; Simko F
    Physiol Res; 1996; 45(4):311-6. PubMed ID: 9085355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heart remodeling in the hereditary hypertriglyceridemic rat: effect of captopril and nitric oxide deficiency.
    Simko F; Luptak I; Matuskova J; Babal P; Pechanova O; Bernatova I; Hulin I
    Ann N Y Acad Sci; 2002 Jun; 967():454-62. PubMed ID: 12079874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of captopril in L-NAME-induced hypertension on the rat myocardium, aorta, brain and kidney.
    Bernátová I; Pechánová O; Simko F
    Exp Physiol; 1999 Nov; 84(6):1095-105. PubMed ID: 10564706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of captopril on cyclic nucleotide concentrations during long-term NO synthase inhibition.
    Pechánová O; Bernátová I
    Physiol Res; 2000; 49(1):55-63. PubMed ID: 10805405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of spironolactone and captopril on nitric oxide and S-nitrosothiol formation in kidney of L-NAME-treated rats.
    Pechanova O; Matuskova J; Capikova D; Jendekova L; Paulis L; Simko F
    Kidney Int; 2006 Jul; 70(1):170-6. PubMed ID: 16710350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human leptin stimulates systemic nitric oxide production in the rat.
    Beltowski J; Wójcicka G; Borkowska E
    Obes Res; 2002 Sep; 10(9):939-46. PubMed ID: 12226143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
    De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G
    Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of angiotensin-converting-enzyme inhibitors in combination with diuretics on blood pressure and renal injury in nitric oxide-deficiency-induced hypertension in rats.
    García-Estañ J; Ortiz MC; O'Valle F; Alcaraz A; Navarro EG; Vargas F; Evangelista S; Atucha NM
    Clin Sci (Lond); 2006 Feb; 110(2):227-33. PubMed ID: 16197366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved survival in rats administered NG-nitro L-arginine methyl ester due to converting enzyme inhibition.
    Michel JB; Xu Y; Blot S; Philippe M; Chatellier G
    J Cardiovasc Pharmacol; 1996 Jul; 28(1):142-8. PubMed ID: 8797148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regression of chronic L -NAME-treatment-induced left ventricular hypertrophy: effect of captopril.
    Bernátová I; Pechánová O; Pelouch V; Simko F
    J Mol Cell Cardiol; 2000 Feb; 32(2):177-85. PubMed ID: 10722795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of ivabradine, captopril and melatonin on the behaviour of rats in L-nitro-arginine methyl ester-induced hypertension.
    Aziriova S; Repova K; Krajcirovicova K; Baka T; Zorad S; Mojto V; Slavkovsky P; Hodosy J; Adamcova M; Paulis L; Simko F
    J Physiol Pharmacol; 2016 Dec; 67(6):895-902. PubMed ID: 28195070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effects of ACE inhibitors on vascular endothelial dysfunction induced by exogenous advanced oxidation protein products in rats.
    Chen SX; Song T; Zhou SH; Liu YH; Wu SJ; Liu LY
    Eur J Pharmacol; 2008 Apr; 584(2-3):368-75. PubMed ID: 18334254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A nitric oxide-generating beta-blocking agent prevents renal injury in the rat remnant kidney model. Comparative study of two beta-blocking drugs, nipradilol and propranolol.
    Takamitsu Y; Nakanishi T; Nishihara F; Hasuike Y; Izumi M; Inoue T; Hiraoka K; Itahana R; Miyagawa K
    Nephron Physiol; 2003; 93(2):p42-50. PubMed ID: 12629270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative contributions of advanced glycation and nitric oxide synthase inhibition to aminoguanidine-mediated renoprotection in diabetic rats.
    Soulis T; Cooper ME; Sastra S; Thallas V; Panagiotopoulos S; Bjerrum OJ; Jerums G
    Diabetologia; 1997 Oct; 40(10):1141-51. PubMed ID: 9349594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.